Lord, Abbett & Co’s Eidos Therapeutics, Inc. Common Stock EIDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-178,608
| Closed | -$23.5M | – | 720 |
|
|
2020
Q4 | $23.5M | Buy |
178,608
+40,708
| +30% | +$5.36M | 0.06% | 385 |
|
|
2020
Q3 | $6.97M | Sell |
137,900
-14,664
| -10% | -$741K | 0.02% | 526 |
|
|
2020
Q2 | $7.27M | Sell |
152,564
-134,862
| -47% | -$6.43M | 0.03% | 520 |
|
|
2020
Q1 | $14.1M | Sell |
287,426
-71,185
| -20% | -$3.49M | 0.06% | 375 |
|
|
2019
Q4 | $20.6M | Sell |
358,611
-164,404
| -31% | -$9.44M | 0.07% | 382 |
|
|
2019
Q3 | $18.8M | Sell |
523,015
-51,451
| -9% | -$1.85M | 0.06% | 417 |
|
|
2019
Q2 | $17.9M | Buy |
574,466
+286,244
| +99% | +$8.9M | 0.06% | 444 |
|
|
2019
Q1 | $6.76M | Buy |
+288,222
| New | +$6.76M | 0.02% | 621 |
|